Call 408.493.1800 | Fax 408.493.1801 | Toll Free 800.891.9699 (US Only) | Email: [email protected]

Protein A/G Sepharose

based on 3 citations in multiple journalsProtein A/G Sepharose34.1 4
Reusable Protein A/G conjugated Sepharose beads with ≥20 mg/ml binding capacity & high flow rate for antibody purification from multiple sources
Catalog #: 6503

In stock

SKU-Size Size Price Qty
6503-1 1 ml
$175.00
6503-5 5 ml
$595.00
6503-25 25 ml
$1,495.00
6503-100 100 ml
$5,650.00
More Sizes Get Quote

Product Details

Highlights • CONTENTS- Supplied as a 50% slurry in 20 % Ethanol/H₂O. ; >5mg Protein A/G per ml Sepharose beads.
• FEATURES- Binding capacity greater than 10 mg/ml of wet gel; High flow rate; Low falling off of rProtein A/G; pH stability 2-10.
• APPLICATIONS- Purification of monoclonal and polyclonal antibodies.
Storage Conditions 4°C
Shipping Conditions Gel Pack
USAGE For Research Use Only! Not For Use in Humans.

Details

Protein A/G Sepharose is prepared by covalently coupling recombinant Protein A/G (contains five Ig-binding regions of protein A and three Ig-binding regions of protein G, Cat. 6502) to 6% cross-linked sepharose beads. The coupling was optimized to give a high binding capacity for IgG. The capacity of IgG binding could be greater than 10 mg of human IgG per ml of wet gel.


Why buy BioVision Products?
Innovation
Affordability
Global Presence
Technical Support
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways.
BioVision is committed to providing the highest quality products at a competitive price.
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery.
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently.
Zhou Z-H, et al. Complement C1 Esterase Inhibitor Levels Linked to Infections and Contaminated Heparin-Associated Adverse Events. PLoS ONE (2012)  7(4): e34978. doi:10.1371/journal.pone.0034978
Kundakovic M et al (2009) Mol. Pharmacol.; 75: 342 - 354.
Dong E. et al (2008) PNAS 105: 13614 - 13619.
For more citations of this product click here
$
Subscribe to our Newsletter!!
and automatically get enrolled into a raffle to win Google Home.
Offer valid for US customers only.